Skip to content
Catalyst

Ganoderma lucidumFinding

Ganoderma lucidum decreases triglycerides

lowersModerate evidenceFinding

01 · The sentence it was drawn from

“As shown in Table 2, after 12 weeks of treatment, the intervention group exhibited significantly lower levels of TG (1.51 ± 0.55 mmol/L), LDL-C (2.68 ± 0.67 mmol/L), and TC (4.87 ± 0.89 mmol/L) compared to the placebo group (TG: 1.88 ± 0.16 mmol/L, LDL-C: 3.20 ± 0.97 mmol/L, TC: 5.25 ± 0.91 mmol/L; p < 0.05).”
Quoted verbatim from Clinical Evaluation of Ganoderma lucidum Spore Oil for Triglyceride Reduction: A Randomized, Double-Blind, Crossover Study.
This finding among the 108 findings on its endpoint

Ganoderma lucidum

Triglycerides

lowers

Who
Adults aged 18 to 65 years with triglycerides of 1.70 to 2.25 mmol/L; 55 per arm analysed
Dose studied
3 softgel capsules twice daily, 0.5 g extract per softgel, approximately 3.0 g/day

Moderate evidencePMID 40077714 · 2025

02 · The study

Study
RCT
Duration
3 months

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6ZJAFTJA3RCCXWE5KBN64RC